Ignite Creation Date:
2025-12-24 @ 4:42 PM
Ignite Modification Date:
2026-04-17 @ 12:15 AM
Study NCT ID:
NCT05475366
Status:
RECRUITING
Last Update Posted:
2025-09-08
First Post:
2022-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
Sponsor:
Institut Curie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IC 2021-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None